原料药
Quetiapine Fumarate
KDMF APIs
Quetiapine Fumarate
韩文名称 | 쿠에티아핀푸마르산염 |
|---|---|
分类 | 中枢神经系统药物 |
CAS No. | 111974-72-2 |
KDMF 登记号 | 20120713-172-I-90-05 |
生产厂商 | Mylan Laboratories Limited Qilu Tianhe Pharmaceutical Co., Ltd. |
规格 | USP |
品目信息
IUPAC Name | 2-[2-(4-{2-thia-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaen-10-yl}piperazin-1-yl)ethoxy]ethan-1-ol |
|---|---|
Synonyms | 2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol |
Description | Initially approved by the FDA in 1997, quetiapine is a second-generation atypical antipsychotic used in schizophrenia, major depression, and bipolar disorder. Quetiapine demonstrates a high level of therapeutic efficacy and low risk of adverse effects during long-term treatment. It is well-tolerated and a suitable option for some patients with high sensitivity to other drugs, such as Clozapine and Olanzapine. |
Certificate of Analysis | If you need more information, please contact us. |
如需规格书 · 检验成绩书等附加资料，请在咨询时一并提出。负责人确认后将回复您。（02-579-1056 · ace@acebiopharm.com）